
Osteoporosis, Postmenopausal - 28 Studies Found
Completed |
: Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis : Postmenopausal Osteoporosis : 2011-05-04 :
|
Completed |
: ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. : Post Menopausal Osteoporosis : 2007-10-16 : Drug: ibandronate [Bonviva/Boniva] 150mg po monthly for 6 months |
Completed |
: SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. : Post Menopausal Osteoporosis : 2007-10-16 :
|
Completed |
: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis : Post Menopausal Osteoporosis : 2002-10-24 :
|
Completed |
: A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis : Post Menopausal Osteoporosis : 2015-11-04 : Drug: Ibandronate Participants will receive oral ibandronate, 150 mg once weekly, for approximately 6 mo |
Completed |
: Mechanisms of Anabolic Osteoporosis Therapy : Osteoporosis, Postmenopausal : 2025-08-02 : early (3-6 weeks) versus late (6-8 months) biopsy |
COMPLETED |
: Multicenter Study in Postmenopausal Women with Osteoporosis, ALVOBOND : Osteoporosis, Postmenopausal : 2025-08-02 : AVT03 (denosumab) is a recombinant fully human IgG2 monoclonal antibody to RANKL to be administered as a subcutaneous injection.Subjects in this |
COMPLETED |
: MAGnesium Effect With ANtiosteoporotic Drugs : Osteoporosis, Postmenopausal : 2025-08-02 :
|